THE US FDA has overnight
approved Qsymia (phentermine
and topiramate extended-release)
for chronic weight management in
adults with a BMI of 30 or greater,
or 27+ with a related condition
such as hypertension, type 2
diabetes or dyslipidemia.
It’s indicated for short-term
weight loss in conjunction with
exercise and a low-calorie diet.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Jul 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Jul 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.